Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum XORTX Therapeutics Inc V.XRTX

Alternate Symbol(s):  XRTX

Healthcare
XORTX Therapeutics Inc. is a Canada-based late-stage clinical pharmaceutical company. The Company develops therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism in orphan disease indications, such as autosomal dominant polycystic kidney disease (ADPKD), as well as type 2 diabetic nephropathy (T2DN) and fatty liver disease. It is working to advance... see more

TSXV:XRTX - Post Discussion

XORTX Therapeutics Inc > XORTX Is Definitely Oversold
View:
Post by NLMoose on Oct 14, 2020 11:38am

XORTX Is Definitely Oversold

While the Food and Drug Adminstration are imprssed with XORTX' preclinical trials, looks like investors are not happy as the stock is getting close to record low levels.

You think that stocks involving companies whom are developing COVID-19 treatments would be seeing increases in share prices, particuarly XORTX, not fall to record low levels.

Comment by nemo3 on Oct 14, 2020 1:25pm
Yeah, not happy with the endless slide downwards in share price. But I will hold as I believe the future is solid for the drugs in the pipeline. But we will definitely be waiting for awhile.  Potential covid treatment for kidneys won't mean anything in price unless they actually get approved and patients get the drug and show that the drug from Xortx works. Might be a good time to pick up ...more  
XORTX Therapeutics Inc